SMARTDIAGNOS: Sample Concentration Integrated Solid-Phase PCR for Next-Generation of Sepsis Diagnostics by Ngo Anh, Tien et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 29, 2019
SMARTDIAGNOS: Sample Concentration Integrated Solid-Phase PCR for Next-
Generation of Sepsis Diagnostics
Ngo Anh, Tien; Aaydha Chidambara, Vinayaka; Nguyen, Trieu; Golabi, Mohsen; Than Linh, Quyen; Wolff,
Anders; Bang, Dang Duong
Publication date:
2018
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Ngo Anh, T., Aaydha Chidambara, V., Nguyen, T., Golabi, M., Than Linh, Q., Wolff, A., & Bang, D. D. (2018).
SMARTDIAGNOS: Sample Concentration Integrated Solid-Phase PCR for Next-Generation of Sepsis
Diagnostics. Abstract from Molecular Diagnostics Europe 2018, Lisboa, Portugal.
Molecular Diagnostics Europe
May 22 - 24, 2018, Lisboa, PORTUGAL
SMARTDIAGNOS: Sample Concentration Integrated Solid-Phase PCR for
Next-Generation of Sepsis Diagnostics
Tien Anh Ngo
Vinayaka Aaydha Chidambara; Trieu Nguyen; Mohsen Golabi; Quyen Than Linh[*]; Anders Wolff[*]; Bang
Duong Dang
Technical University of Denmark, Laboratory of Applied Micro and Nanotechnology, National Food Institute,
Lyngby, Denmark
[*] Technical University of Denmark, Department of Micro and Nanotechnology, BiolabChip Group, Lyngby,
Denmark
At the Third International Consensus Definitions in 2016 Sepsis has defined as "life-
threatening organ dysfunction caused by a dysregulated host response to infection". Sepsis is
one of the ten leading causes of mortality in intensive care units (ICU) worldwide. It is too
complicated to determine the exact number of patients suffering sepsis, but numerous studies
report that the incidence of sepsis is increasing over time, offsetting declining case-fatality
rate. It was estimated that at least 19 million people experience sepsis each year worldwide. In
the USA, sepsis causes more than 200 000 deaths each year, and costs exceed $24 billion per
year for the direct health care. In Europe, 27% death was estimated from 35% of patient in
ICU suffering sepsis and costs 7-21 billion EUR per year for the health sector. To date, early
identification of pathogen causing sepsis is a crucial and unique way to reduce mortality, due
to every hour of delay in appropriate antimicrob ial therapy increases mortality by 5-10%.
Current diagnosis methods for sepsis such as conventional blood culture, MALDI-TOF,
Septifast and other nucleic acid-based multiplex amplification techniques are time consume
(24- 68 hs) and/or low sensitivity. The H2020 EU funded SMARTDIAGNOS project will
generate new diagnostic tools for accurate and earlier pathogen detection and identification. In
this study, a number of innovative technologies such as pathogen concentration, direct PCR,
solid-phase PCR, supercritical angle fluorescence (SAF) microlens array will be developed
and combined into a streamlined point-of-care (POC) and a LAB device to archive
ultrasensitive, rapid, and unlimited multiplexing pathogen detection in blood samples. So far,
the immune-magnetic beads could efficiently concentrate bacterial pathogen at a low
concentration of 101 to 102 CFU/mL from the human pathogen spiked blood sample within 40
min. Integration of a direct solid-phase PCR using a Phusion h ot start DNA polymerase and
optical SAF microlens array in a single polymeric Lab-on-Chip platform allows for highly
sensitive and multiplexed pathogen detection and their antimicrobial resistance genes within 3
hours (including sample preparation and target concentration) with a detection limit of 10
CFU/mL of the blood sample. Fast, sensitive, and accurate detection of the pathogen causing
sepsis and their AMR genes will improve patient outcome, shorten intensive care stay and thus
reduce mortality and health care costs.
